SCHEMBL26147133

SCHEMBL26147133

CCC(C)(CC)c1cnc(-c2ccccc2C)cc1C(C)(CC)CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 15/20 0.41
▸ CYP2C19 P33261 11/20 0.41
▸ CYP2D6 P10635 9/20 0.41
▸ CLK4 Q9HAZ1 8/20 0.41
▸ CYP3A4 P08684 8/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ MAPK1 P28482 4/20 0.39
▸ TSHR P16473 4/20 0.39
▸ TP53 P04637 2/20 0.39
▸ HIF1A Q16665 2/20 0.39
▸ METAP2 P50579 2/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ USP2 O75604 2/20 0.37
▸ APEX1 P27695 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ HPGD P15428 3/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ TGFBR1 P36897 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25497659 0.85 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL22080322 0.82 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL26165300 0.81 CYP1A2 (0.45) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL22674922 0.80 LDHA (0.41) CYP3A4ALDH1A1MAPK1IDO1MEN1
SCHEMBL24913293 0.78 CYP1A2 (0.43) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL25968127 0.78 CYP1A2 (0.43) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL23255785 0.78 CYP1A2 (0.45) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL24066562 0.77 METAP2 (0.39) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL24160881 0.76 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CLK4CYP3A4
SCHEMBL25455629 0.75 CYP11B1 (0.35) ALDH1A1MAPK1METAP2HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331757-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 — — US disclosed
US-20230157154-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157154-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LIFR, SOD1, GLRA3 CYP1A2 2593/4885CYP2C19 2885/4885CYP2D6 3814/4885
US-20230331757-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, SSB, L1CAM CYP1A2 156/4885CYP2C19 1000/4885CYP2D6 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback